Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy

S. Van Binnebeek, C.M. Deroose, K. Baete, C. Terwinghe, B. Vanbilloen, M. Koole, K. Haustermans, L. Mortelmans, C. Verslype, E. van Cutsem, A. Verbruggen, F.M. Mottaghy

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)E579-E581
Number of pages3
JournalJournal of Clinical Oncology
Volume29
Issue number19
DOIs
Publication statusPublished - 1 Jul 2011

Keywords

  • NEUROENDOCRINE TUMORS
  • OCTREOTIDE
  • Y-90-DOTATOC
  • ANTIBODIES
  • DOSIMETRY

Cite this

Van Binnebeek, S., Deroose, C. M., Baete, K., Terwinghe, C., Vanbilloen, B., Koole, M., Haustermans, K., Mortelmans, L., Verslype, C., van Cutsem, E., Verbruggen, A., & Mottaghy, F. M. (2011). Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy. Journal of Clinical Oncology, 29(19), E579-E581. https://doi.org/10.1200/JCO.2010.34.3384